Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Daley

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Blood|June 25, 1998
Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individualsJ E Schmitz, M A Forman, M A Lifton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1985
Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2- subsetsK C Anderson, A W Boyd, D C Fisher, et al.
Blood|April 1, 1983
T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemiaJ D Griffin, R Tantravahi, G P Canellos, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1982
Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiencyE L Reinherz, R Geha, J M Rappeport, et al.
Leukemia|September 17, 2010
Smac mimetics: implications for enhancement of targeted therapies in leukemiaE Weisberg, A Ray, R Barrett, et al.
Leukemia|April 4, 2012
Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitorsE Weisberg, Q Liu, Erik Nelson, et al.
Leukemia|August 22, 2015
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaR H Prabhala, M Fulciniti, D Pelluru, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Blood|June 25, 1998
Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individualsJ E Schmitz, M A Forman, M A Lifton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1985
Isolation and functional analysis of human B cell populations. I. Characterization of the B1+B2+ and B1+B2- subsetsK C Anderson, A W Boyd, D C Fisher, et al.
Blood|April 1, 1983
T-cell surface antigens in a patient with blast crisis of chronic myeloid leukemiaJ D Griffin, R Tantravahi, G P Canellos, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1982
Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiencyE L Reinherz, R Geha, J M Rappeport, et al.
Leukemia|September 17, 2010
Smac mimetics: implications for enhancement of targeted therapies in leukemiaE Weisberg, A Ray, R Barrett, et al.
Leukemia|April 4, 2012
Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and JAK inhibitorsE Weisberg, Q Liu, Erik Nelson, et al.
Leukemia|August 22, 2015
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaR H Prabhala, M Fulciniti, D Pelluru, et al.
Pageof 6